Showing 105 results

Filters Content type: News, Editors' picks, About HIV Topic: Treatment simplification strategies

Research into HIV treatment strategies in which the number of antiretroviral drugs or frequency of dosing is reduced. Some dual therapy regimens have proven to be safe and effective.

Resistance

New HIV drugs should be classed as inferior if they carry a higher risk of resistance

News
22 December 2023
HIV treatment

One-pill-a-day HIV treatments

About HIV
December 2023
Treatment simplification strategies

DTG/3TC vs TDF/FTC dual therapy: ALTAR study results too limited and too early to comment

Editor's pick
i-Base
6 December 2023
Resistance

Dolutegravir resistance is rare, but some risk factors can up the odds

News
6 December 2023
Hepatitis B

HBcAb positivity is a risk factor for failure to achieve complete virologic suppression of HIV-RNA after antiretroviral switch to 3TC+DTG

Editor's pick
NATAP
27 October 2023
Treatment simplification strategies

Reduced-drug treatment becoming common in Paris

News
23 October 2023
Treatment simplification strategies

EACS 2023: Drug-reduced strategies Video

October 2023
Treatment simplification strategies

Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure

News
20 October 2023
Undetectable viral load & treatment as prevention

Two-Drug Regimen as Good as Three in Suppressing HIV in Semen and Rectum in Small Study

Editor's pick
TheBodyPro
22 August 2023
New & experimental HIV treatments

Doravirine/islatravir just as effective as Biktarvy in previously untreated people

News
24 July 2023
HIV treatment for children & young people

NRTI-sparing regimen effective for children and adolescents

News
21 July 2023
Treatment simplification strategies

Dolutegravir alone maintains HIV suppression in those treated early

News
28 June 2023
Treatment simplification strategies

Real-world data confirm the efficacy of dolutegravir-based dual therapy

News
29 May 2023
Changing treatment

Dolutegravir plus darunavir superior to three-drug darunavir combination in second-line treatment

News
23 February 2023
HIV treatment

IDWeek 2022 Study Bites: What’s New in HIV Antiretroviral Therapy

Editor's pick
TheBodyPro
10 November 2022
Resistance

Are people with a shorter history of viral suppression at greater risk of failure of dolutegravir/lamivudine?

News
6 October 2022
Changing treatment

Inflammatory Biomarkers in HIV Support Safety of Switching to 2-Drug Antiretroviral Therapy

Editor's pick
Infectious Disease Advisor
8 September 2022
Treatment simplification strategies

Macrophage Activation for 2 Years After Switch From 3 to 2 Antiretrovirals

Editor's pick
NATAP
5 August 2022
Changing treatment

Outcomes of HIV Virologic Suppression After Switching to Dolutegravir/Lamivudine

Editor's pick
Infectious Disease Advisor
28 March 2022
Treatment simplification strategies

History of drug resistance or virological failure warrants caution when switching to dolutegravir plus lamivudine

News
30 December 2021
Treatment simplification strategies

Implications of historical M184V on use of dual dolutegravir/lamivudine ART

Editor's pick
i-Base
15 November 2021
HIV treatment

Juluca Detailed information

About HIV
September 2021
HIV treatment

Juluca Factsheet

About HIV
September 2021
New & experimental HIV treatments

HIV: Could Another Two-Drug Regimen Be on the Horizon?

Editor's pick
Medscape (requires free registration)
21 July 2021